Works matching IS 15579190 AND DT 2009 AND VI 9 AND IP 2
Results: 20
Successful use of full-dose dexamethasone, high-dose cytarabine, and cisplatin as part of initial therapy in non-Hodgkin and Hodgkin lymphoma with severe hepatic dysfunction.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Abstracts presented at the 13th Annual International Congress on Hematologic Malignancies, February 11-15, 2009; Whistler, British Columbia.
- Published in:
- 2009
- Publication type:
- Journal Article
A pharmacokinetic study evaluating the relationship between treatment efficacy and incidence of adverse events with thalidomide plasma concentrations in patients with refractory multiple myeloma.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Varicella-zoster virus prophylaxis with low-dose acyclovir in patients with multiple myeloma treated with bortezomib.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Melphalan, prednisone, and lenalidomide for newly diagnosed myeloma: kinetics of neutropenia and thrombocytopenia and time-to-event results.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre--positron emission tomography era: A Gruppo Italiano Studio Linfomi (GISL) prospective trial.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
CD43 expression is an adverse prognostic factor in diffuse large B-cell lymphoma.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Meeting highlights from: The 50th Annual Meeting of the American Society of Hematology, San Francisco, CA; December 6-9, 2008.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
The role of biomarkers in the management of patients with lymphoma: promise versus reality.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Varicella-Zoster Virus Prophylaxis with Low-Dose Acyclovir in Patients with Multiple Myeloma Treated with Bortezomib.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 2, p. 151
- By:
- Publication type:
- Article
Successful Use of Full-Dose Dexamethasone, High-Dose Cytarabine, and Cisplatin as Part of Initial Therapy in Non-Hodgkin and Hodgkin Lymphoma with Severe Hepatic Dysfunction.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 2, p. 167
- By:
- Publication type:
- Article
CLINICAL LYMPHOMA & MYELOMA.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 2, p. 114
- By:
- Publication type:
- Article
The Role of Biomarkers in the Management of Patients with Lymphoma: Promise Versus Reality.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 2, p. 121
- By:
- Publication type:
- Article
Meeting Highlights from: The 50th Annual Meeting of the American Society of Hematology; San Francisco, CA; December 6-9, 2008.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 2, p. 124
- By:
- Publication type:
- Article
CD43 Expression Is an Adverse Prognostic Factor in Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 2, p. 133
- By:
- Publication type:
- Article
Response-Guided ABVD Chemotherapy plus Involved-Field Radiation Therapy for Intermediate-Stage Hodgkin Lymphoma in the Pre–Positron Emission Tomography Era: A Gruppo Italiano Studio Linfomi (GISL) Prospective Trial.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 2, p. 138
- By:
- Publication type:
- Article
A Pharmacokinetic Study Evaluating the Relationship Between Treatment Efficacy and Incidence of Adverse Events with Thalidomide Plasma Concentrations in Patients with Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 2, p. 154
- By:
- Publication type:
- Article
Melphalan, Prednisone, and Lenalidomide for Newly Diagnosed Myeloma: Kinetics of Neutropenia and Thrombocytopenia and Time-to-Event Results.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 2, p. 145
- By:
- Publication type:
- Article
Biomarkers and Prognosis in Malignant Lymphomas.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 2, p. 160
- By:
- Publication type:
- Article
Abstracts Presented at the 13th Annual International Congress on Hematologic Malignancies February 11-15, 2009; Whistler, British Columbia.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 2, p. 171
- By:
- Publication type:
- Article